| Bioactivity | N6-Methyl-2-methyl thioadenosine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | N6-Methyl-2-methyl thioadenosine |
| CAS | 6741-71-5 |
| Formula | C10H14N2O5S |
| Molar Mass | 274.29 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |
N6-Methyl-2-methyl thioadenosine
CAS: 6741-71-5 F: C10H14N2O5S W: 274.29
N6-Methyl-2-methyl thioadenosine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activit
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.